Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

B CAMBRIDGE, England, April 27, 2026 /PRNewswire/ — Proteotype Diagnostics Ltd announced its selection as an industrial beneficiary in the HER-CARE Marie Skłodowska-Curie Doctoral Network…
posteditor
posteditor
Articles: 17424

Other News